2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 20:39, 16 December 2023
, 16 December 2023→NMN-HAP
| Line 90: | Line 90: | ||
=== NMN-HAP === | === NMN-HAP === | ||
NMN-HAP is a hydroxyapatite-based nano-drug delivery system for nicotinamide mononucleotide that showed significantly enhancing NMN bioavailability and replenishing NAD+ levels in mice.{{pmid|37862582}} NMN-HAP is currently not available as supplement. | NMN-HAP is a hydroxyapatite-based [[Nano‐Based Delivery Systems|nano-drug delivery system]] for nicotinamide mononucleotide that showed significantly enhancing NMN bioavailability and replenishing NAD+ levels in mice.{{pmid|37862582}} NMN-HAP is currently not available as supplement. | ||
== Bioavailability of NMN == | == Bioavailability of NMN == | ||